3月26日,华润医药(03320)发布截至2024年12月31日止年度的业绩公告。报告期内,公司实现总收益2576.73亿元,较上年2447.04亿元增长5.3%。毛利达到406.89亿元,较上年383.37亿元增长6.1%,毛利率提升至15.8%。然而,公司的净利润为84.03亿元,较2023年的77.75亿元增长8.1%,但本公司权益持有人应占溢利33.51亿元,较上年38.54亿元减少...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.